You are here

Scheduling delegate's final decisions: NCEs, April 2016

Scheduling of medicines and poisons

28 April 2016

Book pagination

Summary

Final decisions on matters not referred to an expert advisory committee

1. New Chemical Entities - medicines for human therapeutic use

Summary of delegate's final decisions

Schedule 4 - New Entries

  • SELEXIPAG
  • VORAPAXAR
  • ALIROCUMAB
  • ELBASVIR
  • GRAZOPREVIR
  • IDARUCIZUMAB
  • HEXYL AMINOLEVULINATE (AS HYDROCHLORIDE)

Implementation date: 1 June 2016

Book pagination